Skip to content
Finance Investment

FTSE-250 CMC Markets Invests in StrikeX Technologies, Cementing Strategic Partnership to Revolutionise the Digital Asset Industry

StrikeX 3 mins read

LONDON, ENGLAND / ACCESSWIRE / June 12, 2023 / StrikeX is thrilled to announce the successful completion of an investment and strategic partnership with CMC Markets, an award-winning* FTSE 250 financial services provider. CMC Markets has acquired a 33% stake in StrikeX Technologies, with two of its senior executives being welcomed to the StrikeX board, bringing with them a wealth of expertise and experience. This is a significant milestone for both companies and the digital asset industry as a whole. By combining StrikeX's expertise in tokenisation and self-custody technologies with CMC Markets' extensive experience in financial services, both companies are now well-positioned to transform the way people and businesses invest in digital assets.

StrikeX & CMC Markets partnership
StrikeX & CMC Markets partnership

Joe Jowett, StrikeX CEO and Co-Founder, expressed his excitement for the deal and the potential it holds, saying:
"Our partnership with CMC Markets will bolster our position as early frontrunners in this dynamic and fast-moving industry, whilst validating our long-term vision and strategy. We strive to pioneer the delivery of traditional financial instruments, such as equities, commodities and bonds to the blockchain, whilst guaranteeing security, compliance, and ease of access via intuitive, secure, and user-friendly products. We are excited by the opportunity this partnership brings and we look forward to sharing more updates as we continue to grow and innovate."

Lord Cruddas, CMC's founder and CEO, added:
"This is a major strategic investment in the growing Web 3.0 technology space of which StrikeX Technologies gives us access to the very best technology and advancements. StrikeX is a brilliant, young, dynamic company, with a very talented team that has its finger on the pulse of fast-moving technologies. We are all very excited about working together as we continue to diversify our business with the latest technology, products and wallet settlement."

*№1 Platform Technology Forex Brokers 2022
*Best White Label Provider B2B Global Forex Awards 2023
*№1 Web platform Forex Broker Awards 2023

CMC Markets Plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The Group serves retail and institutional clients through regulated offices and branches in 12 countries, with a significant presence in the UK, Australia, Germany, and Singapore. CMC offers an award-winning, online, and mobile trading platform, enabling clients to trade up to 10,000 financial instruments across shares, indices, foreign currencies, commodities, and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at https://www.cmcmarkets.com/group/.

StrikeX Technologies was founded in early 2021 and is developing a suite of user-centric and innovative blockchain solutions, from web3-enabled software to pioneering advancements in tokenisation technology. Learn more about StrikeX and its subsidiaries at  https://strikex.com and  https://tradestrike.io.

Contact Information
Joe Jowett
CEO & Co-Founder
[email protected]

SOURCE: StrikeX Technologies Ltd.

.


View source version on accesswire.com:
https://www.accesswire.com/760764/FTSE-250-CMC-Markets-Invests-in-StrikeX-Technologies-Cementing-Strategic-Partnership-to-Revolutionise-the-Digital-Asset-Industry

More from this category

  • Finance Investment, Medical Health Aged Care
  • 17/03/2026
  • 10:25
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Advances StemSmart(TM) Manufacturing Scale-Up as Phase 2 Crohn’s Disease Trial Preparations Progress

Perth, Australia – 17 March 2026 | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has reached an important development milestone with the commencement of the first technology transfer manufacturing run of its patented StemSmart™ mesenchymal stem cell (MSC) process at leading Australian cell therapy manufacturer Q-Gen Cell Therapeutics. The initiation of the manufacturing run represents a key step in the transfer of the StemSmart™ manufacturing process to a large-scale clinical contract manufacturer that is then capable of providing adequate supply for Phase 2 clinical trials and future commercialisation. Q-Gen Cell Therapeutics, located within the QIMR Berghofer Medical Research Institute in Brisbane, is one…

  • Contains:
  • Environment, Finance Investment
  • 17/03/2026
  • 10:21
HESTA

HESTA launches search for Australia’s early childhood education champions

17 March 2026 The search for Australia’s most outstanding early childhood educators is underway with nominations opening today for the 2026 HESTA Early Childhood…

  • Contains:
  • Finance Investment, Oil Mining Resources
  • 17/03/2026
  • 09:57
Jane Morgan Management

Moab to acquire additional uranium tenements at Manyoni Project in Tanzania

Perth, Australia – 17 March 2026 Moab Minerals Limited (ASX: MOM) has strengthened its position at the Manyoni Uranium Project in Tanzania after securing the transfer of four uranium tenements adjacent to the project area from AuKing Limited (ASX: AKN). The tenements have been transferred to Moab’s Tanzanian subsidiary, Katika Resources Limited, and expand the Company’s exploration footprint across a prospective palaeochannel uranium system already mineralised at Manyoni. The acquisition forms part of Moab’s strategy to consolidate a strategic uranium landholding in central Tanzania and advance exploration across multiple targets associated with the broader palaeo-drainage system. Historical drilling across the…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.